Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Ruling against Becton Dickinson unit positive for Tela Bio, says Lake Street » 08:52
09/08/22
09/08
08:52
09/08/22
08:52
TELA

Tela Bio

$8.85 /

+0.07 (+0.80%)

, BDX

Becton Dickinson

$258.12 /

+6.885 (+2.74%)

Lake Street analyst Frank…

Lake Street analyst Frank Takkinen notes that C.R. Bard, a unit of Becton Dickinson (BDX), was ordered last week to pay $4.8M in a lawsuit related to its hernia mesh, Ventralex. He calls this news positive for Tela Bio (TELA), citing his thesis that the company's OviTex for hernia repair is set to take significant market share from incumbent players. OviTex is "the clear competitive winner in the $1B+ hernia repair market" given that Tela has "a significantly better product that is cheaper and on contract with the two largest group purchasing organizations," according to Takkinen, who reiterates a Buy rating and $17 price target on Tela Bio shares.

ShowHide Related Items >><<
TELA Tela Bio
$8.85 /

+0.07 (+0.80%)

BDX Becton Dickinson
$258.12 /

+6.885 (+2.74%)

TELA Tela Bio
$8.85 /

+0.07 (+0.80%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
BDX Becton Dickinson
$258.12 /

+6.885 (+2.74%)

08/04/22 Piper Sandler
Piper waits for a better Becton Dickinson entry point despite 'impressive' sales
08/01/22 Morgan Stanley
Embecta initiated with an Equal Weight at Morgan Stanley
07/18/22 Stifel
Becton Dickinson price target lowered to $280 from $290 at Stifel
07/11/22 Citi
Becton Dickinson downgraded to Sell from Neutral at Citi
TELA Tela Bio
$8.85 /

+0.07 (+0.80%)

BDX Becton Dickinson
$258.12 /

+6.885 (+2.74%)

  • 16
    Aug
BDX Becton Dickinson
$258.12 /

+6.885 (+2.74%)

TELA Tela Bio
$8.85 /

+0.07 (+0.80%)

BDX Becton Dickinson
$258.12 /

+6.885 (+2.74%)

BDX Becton Dickinson
$258.12 /

+6.885 (+2.74%)

Over a month ago
Conference/Events
Tela Bio participates in a conference call with Lake Street » 13:45
08/16/22
08/16
13:45
08/16/22
13:45
TELA

Tela Bio

$8.16 /

-0.985 (-10.78%)

Conference call with…

Conference call with premier hernia surgeon, Dr. Paul Szotek, to be held on August 16 at 2 pm hosted by Lake Street. Webcast Link

ShowHide Related Items >><<
TELA Tela Bio
$8.16 /

-0.985 (-10.78%)

TELA Tela Bio
$8.16 /

-0.985 (-10.78%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
TELA Tela Bio
$8.16 /

-0.985 (-10.78%)

  • 16
    Aug
TELA Tela Bio
$8.16 /

-0.985 (-10.78%)

Syndicate
Tela Bio 4M share Spot Secondary priced at $8.00 » 06:04
08/16/22
08/16
06:04
08/16/22
06:04
TELA

Tela Bio

$9.10 /

+0.25 (+2.82%)

Lake Street acted as sole…

Lake Street acted as sole book running manager for the offering.

ShowHide Related Items >><<
TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

  • 16
    Aug
TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

Conference/Events
Tela Bio participates in a conference call with Lake Street » 04:55
08/16/22
08/16
04:55
08/16/22
04:55
TELA

Tela Bio

$9.10 /

+0.25 (+2.82%)

Conference call with…

Conference call with premier hernia surgeon, Dr. Paul Szotek, to be held on August 16 at 2 pm hosted by Lake Street. Webcast Link

ShowHide Related Items >><<
TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

  • 16
    Aug
TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

Syndicate
Tela Bio files to sell common stock, no amount given » 16:05
08/15/22
08/15
16:05
08/15/22
16:05
TELA

Tela Bio

$9.10 /

+0.25 (+2.82%)

Lake Street Capital…

Lake Street Capital Markets, LLC is acting as sole book-running manager for the proposed offering.

ShowHide Related Items >><<
TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

TELA Tela Bio
$9.10 /

+0.25 (+2.82%)

Earnings
Tela Bio reports Q2 EPS (88c), consensus (62c) » 16:19
08/10/22
08/10
16:19
08/10/22
16:19
TELA

Tela Bio

$8.55 /

-0.16 (-1.84%)

Reports Q2 revenue…

Reports Q2 revenue $10.4M, consensus $10.12M.

ShowHide Related Items >><<
TELA Tela Bio
$8.55 /

-0.16 (-1.84%)

TELA Tela Bio
$8.55 /

-0.16 (-1.84%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
TELA Tela Bio
$8.55 /

-0.16 (-1.84%)

TELA Tela Bio
$8.55 /

-0.16 (-1.84%)

Conference/Events
Tela Bio participates in a conference call with Lake Street » 09:57
08/08/22
08/08
09:57
08/08/22
09:57
TELA

Tela Bio

$8.75 /

+0.1 (+1.16%)

Conference call with…

Conference call with premier hernia surgeon, Dr. Paul Szotek, to be held on August 16 at 2 pm hosted by Lake Street. Webcast Link

ShowHide Related Items >><<
TELA Tela Bio
$8.75 /

+0.1 (+1.16%)

TELA Tela Bio
$8.75 /

+0.1 (+1.16%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
TELA Tela Bio
$8.75 /

+0.1 (+1.16%)

TELA Tela Bio
$8.75 /

+0.1 (+1.16%)

Hot Stocks
Tela Bio highlights results from BRAVO, ReBAR studies » 08:16
08/04/22
08/04
08:16
08/04/22
08:16
TELA

Tela Bio

$8.42 /

+0.22 (+2.68%)

TELA Bio announced that…

TELA Bio announced that two studies examining clinical outcomes with use of its OviTex Reinforced Tissue Matrix will be presented at the 2022 American Hernia Society Meeting. The conference, taking place from September 14-16, 2022, in Charlotte, North Carolina, will highlight the outcomes of two studies that underscore the efficacy of OviTex. 24-Month results of the BRAVO Study: A prospective, multi-center study evaluating the clinical outcomes of ventral hernias treated with OviTex 1S Permanent Reinforced Tissue Matrix: TELA Bio's prospective, single-arm, multi-center clinical trial was designed to evaluate the clinical performance of OviTex 1S with permanent polymer embroidery for primary or recurrent ventral hernias in 92 enrolled patients. OviTex 1S Permanent demonstrated a 2.6% recurrence rate in ventral hernias repaired using open, laparoscopic, or robotic techniques at the 24-month time point. Surgical site occurrences were observed in 38% of the study population, where 78% of all enrolled patients were characterized as high risk for experiencing an SSO based on at least one known risk factor. These risk factors included obesity, active smoking, COPD, diabetes mellitus, coronary artery disease, or advanced age. This study included diverse clinical scenarios for ventral hernias as OviTex 1S was utilized in open and minimally invasive procedures, various planes of placement, and CDC wound classes I-III. The use of OviTex 1S in BRAVO patients also resulted in clinically meaningful improvements in their quality of life and perceived health. Improvements were reported as early as 90 days after surgery and this improvement persisted over the 24 months of follow-up. These BRAVO 24-Month results follow the publication of the BRAVO 12-Month study, released in November 2021 in the Journal of Clinical Medicine. Robotic Reinforced Biologic Augmented Repair of Over 150 Inguinal Hernias: 2-Year Outcomes: This retrospective study examined the two-year recurrence rate of the robotic-assisted reinforced biologic augmented repair of inguinal hernias from June 2018 to April 2022. All repairs employed the standard robotic transabdominal preperitoneal approach combined with the novel ReBAR technique, which consists of suture closure of the defect followed by a biologic mesh reinforcement. After two years, only three recurrences were identified from the 157 inguinal hernias repaired using the ReBAR technique - a rate of 1.9%, and only two SSOs were identified in this cohort.

ShowHide Related Items >><<
TELA Tela Bio
$8.42 /

+0.22 (+2.68%)

TELA Tela Bio
$8.42 /

+0.22 (+2.68%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
TELA Tela Bio
$8.42 /

+0.22 (+2.68%)

TELA Tela Bio
$8.42 /

+0.22 (+2.68%)

Hot Stocks
Tela Bio awarded Synthetic Bioabsorbable products agreement with Premier » 07:03
07/20/22
07/20
07:03
07/20/22
07:03
TELA

Tela Bio

$8.03 /

-0.025 (-0.31%)

, PINC

Premier

$37.30 /

+0.53 (+1.44%)

TELA Bio (TELA) announced…

TELA Bio (TELA) announced that it has been awarded a group purchasing agreement for Synthetic Bioabsorbable Mesh Products with Premier (PINC). Effective October 1st, 2022, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for OviTex and OviTex PRS Reinforced Tissue Matrix. "We are both grateful and honored to be awarded this important agreement," said Antony Koblish, President and CEO of TELA Bio. "This is a significant opportunity for our company, and we look forward to working with Premier members to provide their surgeons and patients with access to our advanced soft-tissue repair portfolio."

ShowHide Related Items >><<
TELA Tela Bio
$8.03 /

-0.025 (-0.31%)

PINC Premier
$37.30 /

+0.53 (+1.44%)

TELA Tela Bio
$8.03 /

-0.025 (-0.31%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
PINC Premier
$37.30 /

+0.53 (+1.44%)

05/04/22 Canaccord
Premier price target lowered to $44 from $47 at Canaccord
05/04/22 Piper Sandler
Premier upgraded to Overweight from Neutral at Piper Sandler
04/13/22 Guggenheim
Premier initiated with a Neutral at Guggenheim
03/31/22 Credit Suisse
Premier assumed with an Underperform at Credit Suisse
TELA Tela Bio
$8.03 /

-0.025 (-0.31%)

PINC Premier
$37.30 /

+0.53 (+1.44%)

PINC Premier
$37.30 /

+0.53 (+1.44%)

TELA Tela Bio
$8.03 /

-0.025 (-0.31%)

PINC Premier
$37.30 /

+0.53 (+1.44%)

Over a quarter ago
Conference/Events
Tela Bio participates in a conference call with Lake Street » 10:45
06/15/22
06/15
10:45
06/15/22
10:45
TELA

Tela Bio

$5.69 /

-0.27 (-4.53%)

Conference call with CEO…

Conference call with CEO Koblish and CFO Cuca will be held on June 15 at 11 am hosted by Lake Street. Webcast Link

ShowHide Related Items >><<
TELA Tela Bio
$5.69 /

-0.27 (-4.53%)

TELA Tela Bio
$5.69 /

-0.27 (-4.53%)

05/31/22 Lake Street
Tela Bio initiated with a Buy at Lake Street
TELA Tela Bio
$5.69 /

-0.27 (-4.53%)

TELA Tela Bio
$5.69 /

-0.27 (-4.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.